Joseph Larosa - Jun 24, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Jun 24, 2024
Transactions value $
-$3,721,049
Form type
4
Date filed
6/25/2024, 04:39 PM
Previous filing
Jun 12, 2024
Next filing
Jul 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $8.03M +14.5K +39.66% $555.67 50.9K Jun 24, 2024 Direct
transaction REGN Common Stock Tax liability -$11.8M -11.1K -21.78% $1,060.13 39.8K Jun 24, 2024 Direct
holding REGN Common Stock 371 Jun 24, 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -14.5K -50% $0.00 14.5K Jun 24, 2024 Common Stock 14.5K $555.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.